Literature DB >> 16015356

Sizing up miRNAs as cancer genes.

Carlos Caldas, James D Brenton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16015356     DOI： 10.1038/nm0705-712

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  87 in total

1.  Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

Authors:  Jen-Liang Su; Poshen B Chen; Ya-Huey Chen; Shang-Chih Chen; Yi-Wen Chang; Yi-Hua Jan; Xiaoyun Cheng; Michael Hsiao; Mien-Chie Hung
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 2.  Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

Authors:  George A Calin; Carlo M Croce
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  A microRNA detection system based on padlock probes and rolling circle amplification.

Authors:  Søren Peter Jonstrup; Jørn Koch; Jørgen Kjems
Journal:  RNA       Date:  2006-08-03       Impact factor: 4.942

4.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

Authors:  Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

5.  A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

Authors:  Amy L Collins; Sylwia Wojcik; James Liu; Wendy L Frankel; Hansjuerg Alder; Lianbo Yu; Thomas D Schmittgen; Carlo M Croce; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

Review 6.  MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.

Authors:  Satyanarayana Rachagani; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2009-12-09       Impact factor: 8.679

7.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

8.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

Authors:  Li-Xu Yan; Xiu-Fang Huang; Qiong Shao; Ma-Yan Huang; Ling Deng; Qiu-Liang Wu; Yi-Xin Zeng; Jian-Yong Shao
Journal:  RNA       Date:  2008-09-23       Impact factor: 4.942

9.  MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

Authors:  Yunqing Li; Fadila Guessous; Ying Zhang; Charles Dipierro; Benjamin Kefas; Elizabeth Johnson; Lukasz Marcinkiewicz; Jinmai Jiang; Yanzhi Yang; Thomas D Schmittgen; Beatriz Lopes; David Schiff; Benjamin Purow; Roger Abounader
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

10.  Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.

Authors:  Yong Yang; Peng Zhang; Yanfeng Zhao; Jie Yang; Gening Jiang; Jie Fan
Journal:  Cancer Biol Ther       Date:  2015-10-22       Impact factor: 4.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.